| SEPTIN2 Protein |
|---|
| Gene | [SEPTIN2](/genes/septin2) |
| Protein Name | Septin-2 |
| UniProt ID | [Q15021](https://www.uniprot.org/uniprot/Q15021) |
| Molecular Weight | 41.5 kDa |
| Subcellular Localization | Cytoskeleton, plasma membrane, axon initial segment |
| Protein Family | Septin GTPase family |
| PDB Structures | 2QK9, 4LYG, 5C2D |
SEPTIN2 (Septin-2) is a member of the septin family of GTP-binding proteins that form hetero-oligomeric complexes essential for cytoskeletal organization and membrane dynamics. In neurons, septins are critically involved in maintaining synaptic structure, vesicle trafficking, and neuronal polarity. SEPTIN2 dysfunction has been implicated in several neurodegenerative diseases, particularly Parkinson's disease.
The SEPTIN2 protein exhibits the characteristic septin architecture:
- N-terminal Polybasic Region: Highly charged region that mediates membrane association and phosphoinositide binding
- GTP-Binding Domain (G domain): Conserved GTPase domain (~300 aa) with switch I and II regions that undergo conformational changes during GTP hydrolysis
- Septin Unique Element (SUE): A ~45 amino acid insertion specific to septins
- C-terminal Coiled-Coil Domain: Mediates homomeric and heteromeric interactions with other septins
SEPTIN2 forms hexameric or octameric rods that assemble into higher-order structures including filaments, rings, and palisades.
In the healthy nervous system, SEPTIN2 plays essential roles:
- Forms heterooligomeric complexes with SEPTIN3, SEPTIN5, SEPTIN6, and SEPTIN7
- Creates diffusion barriers at the axon initial segment (AIS)
- Controls protein and organelle trafficking between somatodendritic and axonal compartments
- Maintains neuronal polarity
- Localizes to presynaptic terminals
- Regulates synaptic vesicle clustering and release
- Controls postsynaptic density organization
- Modulates neurotransmitter receptor trafficking
- Associates with plasma membrane microdomains
- Regulates exocytosis and endocytosis
- Controls dendritic spine morphology
- Involved in cytokinesis in neural progenitor cells
- Ensures proper neuron numbers during development
SEPTIN2 dysfunction is implicated in several neurodegenerative disorders:
- SEPTIN2 is downregulated in PD substantia nigra
- Colocalizes with Lewy bodies (alpha-synuclein aggregates)
- Genetic variants associated with increased PD risk
- Involved in mitochondrial quality control through interaction with PARKIN
- Altered septin expression in AD brain
- SEPTIN2 accumulates in amyloid plaques
- Potential role in tau pathology
- Contributes to synaptic loss
- Mutant huntingtin affects septin assembly
- Dysregulation of SEPTIN2 in HD models
- Contributes to transcriptional alterations
- SEPTIN2 aggregates found in ALS motor neurons
- Interactions with TDP-43 pathology
- Altered membrane trafficking in ALS
- SEPTIN2 variants associated with seizure disorders
- Dysregulated vesicle release in epileptic neurons
- Septin assembly modulators: Compounds that promote proper septin polymerization
- GTPase activity modulators: Targeting the GTP-binding function
- AAV-mediated SEPTIN2 overexpression to restore function
- CRISPR approaches to correct pathogenic variants
- siRNA for variant reduction in gain-of-function scenarios
- Recombinant septin complexes for replacement
- Cell-penetrating peptides targeting septin interactions
SEPTIN2 interacts with key neuronal proteins:
- SEPTIN5: Forms heterooligomers in presynaptic terminals
- SEPTIN7: Critical for higher-order assembly
- SEPTIN6: Component of neuronal septin complexes
- Ankyrin-G: Maintains axon initial segment barrier
- SNAP25: Regulates synaptic vesicle release
- PARKIN: Mitochondrial quality control
- Alpha-synuclein: PD-related protein interaction
- Ito et al., Septin dysfunction in neurodegenerative diseases (2024)
- Barbee et al., SEPTIN2 and neuronal polarity (2023)
- Marty et al., Septin barriers in axon initial segment (2022)
- Tóth et al., SEPTIN2 in Parkinson's disease (2021)
- Sellier et al., Septin accumulation in neurodegeneration (2020)